The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Stryker Corp

NYSE: SYK
Last

(U.S.) $95.99

Today's change0.00 0.00%
Updated July 6 4:05 PM EDT. Delayed by at least 15 minutes.
 

Stryker Corp

NYSE: SYK
Last

(U.S.) $95.99

Today's change0.00 0.00%
Updated July 6 4:05 PM EDT. Delayed by at least 15 minutes.

Stryker Corp closed at (U.S.)$95.99.

Over the last five days, shares have gained 0.66%, but are currently unchanged over the last year to date. Shares have outperformed the S&P 500 by 7.90% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $95.99
  • High--
  • Low--
  • Bid / Ask(U.S.) $95.07 / (U.S.) $97.71
  • YTD % change+1.76%
  • Volume0
  • Average volume (10-day)1,012,753
  • Average volume (1-month)926,032
  • Average volume (3-month)1,107,977
  • 52-week range(U.S.) $77.87 to (U.S.) $98.24
  • Beta1.10
  • Trailing P/E54.97×
  • P/E 1 year forward19.07×
  • Forward PEG2.33×
  • Indicated annual dividend(U.S.) $1.38
  • Dividend yield1.44%
  • Trailing EPS(U.S.) $1.75
Updated July 6 4:05 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.86%

Based on its net profit margin of 6.86%, Stryker Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue2,3792,6182,3892,363
Total other revenue--------
Total revenue2,3792,6182,3892,363
Gross profit1,5591,7311,5771,555
Total cost of revenue820887812808
Total operating expense1,9732,1501,9392,166
Selling / general / administrative87895851853
Research & development152153153158
Depreciation / amortization49465047
Interest expense (income), net operating--------
Unusual expense (income)7496973300
Other operating expenses, total--------
Operating income406468450197
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax377461425167
Income after tax22426057128
Income tax, total15320136839
Net income22426057128
Total adjustments to net income--------
Net income before extra. items22426057128
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items22426057128
Inc. avail. to common incl. extra. items22426057128
Diluted net income22426057128
Dilution adjustment--00--
Diluted weighted average shares384383383383
Diluted EPS excluding extraordinary itemsvalue per share0.580.680.150.33
Dividends per sharevalue per share0.350.350.310.31
Diluted normalized EPSvalue per share0.702.110.270.94